vcvibes

Fca Health Innovations Ii Management LLC

Emerging manager

SEC exempt reporting adviser (venture capital exemption).

Website
https://www.fcavp.com
HQ
TN
Visit their website

FCA Venture Partners invests in companies transforming healthcare through innovative technology and services. Its portfolio includes Azra AI for oncology patient triage, Watershed Health for care coordination with health plans, eBlu Solutions for prior authorization, Enable Dental for senior care facilities, and ShiftWizard for healthcare workforce management. Matt King and Andrew Bouldin are managing partners. Jeffrey Kasher was appointed to the board.

01 · Says / Does

TagSaysDoesHistorically (to 2020)
StagesSeed, Series A, Series BNot enough dated dealsSeries A, Series B
SectorsAI applications, Healthtech, Digital healthNot enough dated dealsHealthtech, Enterprise SaaS, Medical devices, Biotech
RegionsNot statedNot enough dated dealsTN

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

Historical focus (through 2020), derived from historical deal data.

YearDealsTop sectors
20001Healthtech
20031Biotech, Manufacturing, Medical devices
20041Healthtech
20072Healthtech, Biotech, Enterprise SaaS
20084Enterprise SaaS, Fintech, Healthtech
20092Biotech, Healthtech, Medical devices
20102Healthtech, Enterprise SaaS
20112Healthtech, Medical devices
20126Healthtech, Biotech, Enterprise SaaS
20131Healthtech
20147Healthtech, Biotech, Enterprise SaaS
20151Healthtech
201611Healthtech, Biotech, Data analytics
20172Healthtech, Enterprise SaaS, HR and future of work
20183Enterprise SaaS, Healthtech, Medical devices
20192Healthtech, Medical devices, Mobility
20202Healthtech, Medical devices, Consumer

Stage mix over time

2010 Series A: 12010 Series B: 1102011 Series A: 12011 Series B: 1112012 Series A: 22012 Series B: 22012 Growth: 1122013 Series B: 1132014 Series A: 32014 Series B: 214152016 Series A: 22016 Series B: 22016 Growth: 1162017 Series A: 2172018 Series A: 2182019 Series A: 12019 Series B: 1192020 Series A: 22021222324252026 Series A: 126
  • Pre-seed
  • Seed
  • Series A
  • Series B
  • Growth
Share of rounds by stage, per year. Striped years have fewer than 3 rounds.Historical focus (through 2020), derived from historical deal data.From public announcements.
Rounds by stage and year
YearPre-seedSeedSeries ASeries BGrowth
201000110
201100110
201200221
201300010
201400320
201500000
201600221
201700200
201800200
201900110
202000200
202100000
202200000
202300000
202400000
202500000
202600100

02 · Fund history

FundYearSizeStatus
FCA Health Innovations III AI, LP

Invests in healthcare companies transforming care through innovative technology and services across providers, payers, pharma, and innovative care delivery. Focuses on seed and Series A/B companies with 50%+ annual growth. Inferred from the firm's website

2026$3.1M to $175M (Form D)Raising
FCA Health Innovations III QP, LP

Invests in healthcare companies transforming care through innovative technology and services across providers, payers, pharma, and innovative care delivery. Focuses on seed and Series A/B companies with 50%+ annual growth. Inferred from the firm's website

2026$49.88M to $175M (Form D)Raising

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

06 · Sources

  1. https://www.fcavp.com
  2. https://www.fcavp.com/our-team
  3. https://www.fcavp.com/portfolio
  4. https://www.fcavp.com/insights/patientpartner-appoints-former-eli-lilly-executive-dr-jeffrey-kasher-to-board
  5. https://www.fcavp.com/strategy

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026